Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 432

1.

Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.

Davis KL, Fox E, Merchant MS, Reid JM, Kudgus RA, Liu X, Minard CG, Voss S, Berg SL, Weigel BJ, Mackall CL.

Lancet Oncol. 2020 Apr;21(4):541-550. doi: 10.1016/S1470-2045(20)30023-1. Epub 2020 Mar 17.

PMID:
32192573
2.

Older mothers produce more successful daughters.

Kroeger SB, Blumstein DT, Armitage KB, Reid JM, Martin JGA.

Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4809-4814. doi: 10.1073/pnas.1908551117. Epub 2020 Feb 18.

PMID:
32071200
3.

CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants.

Zhang L, Sarangi V, Moon I, Yu J, Liu D, Devarajan S, Reid JM, Kalari KR, Wang L, Weinshilboum R.

Clin Transl Sci. 2020 Jan 31. doi: 10.1111/cts.12758. [Epub ahead of print]

PMID:
32004414
4.

Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312).

Cole KA, Pal S, Kudgus RA, Ijaz H, Liu X, Minard CG, Pawel BR, Maris JM, Haas-Kogan DA, Voss SD, Berg SL, Reid JM, Fox E, Weigel BJ.

Clin Cancer Res. 2020 Mar 15;26(6):1213-1219. doi: 10.1158/1078-0432.CCR-19-3470. Epub 2019 Dec 19.

PMID:
31857431
5.
6.

Testing predictions of inclusive fitness theory in inbreeding relatives with biparental care.

Gow EA, Arcese P, Dagenais D, Sardell RJ, Wilson S, Reid JM.

Proc Biol Sci. 2019 Dec 4;286(1916):20191933. doi: 10.1098/rspb.2019.1933. Epub 2019 Dec 4.

7.

Phase 1/2 trial of talazoparib in combination with temozolomide in children and adolescents with refractory/recurrent solid tumors including Ewing sarcoma: A Children's Oncology Group Phase 1 Consortium study (ADVL1411).

Schafer ES, Rau RE, Berg SL, Liu X, Minard CG, Bishop AJR, Romero JC, Hicks MJ, Nelson MD Jr, Voss S, Reid JM, Fox E, Weigel BJ, Blaney SM.

Pediatr Blood Cancer. 2020 Feb;67(2):e28073. doi: 10.1002/pbc.28073. Epub 2019 Nov 14.

PMID:
31724813
8.

Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group.

Kopp LM, Malempati S, Krailo M, Gao Y, Buxton A, Weigel BJ, Hawthorne T, Crowley E, Moscow JA, Reid JM, Villalobos V, Randall RL, Gorlick R, Janeway KA.

Eur J Cancer. 2019 Nov;121:177-183. doi: 10.1016/j.ejca.2019.08.015. Epub 2019 Oct 3.

PMID:
31586757
9.

Correction: Antibody-Targeted Chemotherapy for the Treatment of Melanoma.

Nevala WK, Buhrow SA, Knauer DJ, Reid JM, Atanasova EA, Markovic SN.

Cancer Res. 2019 Sep 1;79(17):4551. doi: 10.1158/0008-5472.CAN-19-1930. No abstract available.

10.

Pharmacogenomics of Cytochrome P450 of Nimodipine Metabolism After Aneurysmal Subarachnoid Hemorrhage.

Peacock SH, James C, Turnbull MT, Cowart JB, Reid JM, Freeman WD.

J Neurosci Nurs. 2019 Oct;51(5):238-242. doi: 10.1097/JNN.0000000000000464. Review.

PMID:
31469704
11.

Science policies: How should science funding be allocated? An evolutionary biologists' perspective.

Meirmans S, Butlin RK, Charmantier A, Engelstädter J, Groot AT, King KC, Kokko H, Reid JM, Neiman M.

J Evol Biol. 2019 Aug;32(8):754-768. doi: 10.1111/jeb.13497. Epub 2019 Jul 5.

12.

Individuals' expected genetic contributions to future generations, reproductive value, and short-term metrics of fitness in free-living song sparrows (Melospiza melodia).

Reid JM, Nietlisbach P, Wolak ME, Keller LF, Arcese P.

Evol Lett. 2019 Apr 25;3(3):271-285. doi: 10.1002/evl3.118. eCollection 2019 Jun.

13.

Vaginal Diazepam for Nonrelaxing Pelvic Floor Dysfunction: The Pharmacokinetic Profile.

Larish AM, Dickson RR, Kudgus RA, McGovern RM, Reid JM, Hooten WM, Nicholson WT, Vaughan LE, Burnett TL, Laughlin-Tommaso SK, Faubion SS, Green IC.

J Sex Med. 2019 Jun;16(6):763-766. doi: 10.1016/j.jsxm.2019.03.003. Epub 2019 Apr 19.

PMID:
31010782
14.

A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921).

Mossé YP, Fox E, Teachey DT, Reid JM, Safgren SL, Carol H, Lock RB, Houghton PJ, Smith MA, Hall D, Barkauskas DA, Krailo M, Voss SD, Berg SL, Blaney SM, Weigel BJ.

Clin Cancer Res. 2019 Jun 1;25(11):3229-3238. doi: 10.1158/1078-0432.CCR-18-2675. Epub 2019 Feb 18.

PMID:
30777875
15.

Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19.

Devarajan S, Moon I, Ho MF, Larson NB, Neavin DR, Moyer AM, Black JL, Bielinski SJ, Scherer SE, Wang L, Weinshilboum RM, Reid JM.

Drug Metab Dispos. 2019 Apr;47(4):425-435. doi: 10.1124/dmd.118.084269. Epub 2019 Feb 11. Erratum in: Drug Metab Dispos. 2020 Feb;48(2):85.

16.

Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review.

Barreto EF, Rule AD, Murad MH, Kashani KB, Lieske JC, Erwin PJ, Steckelberg JM, Gajic O, Reid JM, Kane-Gill SL.

Mayo Clin Proc. 2019 Mar;94(3):500-514. doi: 10.1016/j.mayocp.2018.08.002. Epub 2019 Jan 31.

PMID:
30713050
17.

Nonequivalent lethal equivalents: Models and inbreeding metrics for unbiased estimation of inbreeding load.

Nietlisbach P, Muff S, Reid JM, Whitlock MC, Keller LF.

Evol Appl. 2018 Oct 23;12(2):266-279. doi: 10.1111/eva.12713. eCollection 2019 Feb.

18.

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2.

Dudenkov TM, Liu D, Cairns J, Devarajan S, Zhuang Y, Ingle JN, Buzdar AU, Robson ME, Kubo M, Batzler A, Barman P, Jenkins GD, Carlson EE, Goetz MP, Northfelt DW, Moreno-Aspitia A, Desta Z, Reid JM, Kalari KR, Wang L, Weinshilboum RM.

Clin Pharmacol Ther. 2019 Jul;106(1):219-227. doi: 10.1002/cpt.1359. Epub 2019 Mar 18.

19.

Cumulative reproductive costs on current reproduction in a wild polytocous mammal.

Kroeger SB, Blumstein DT, Armitage KB, Reid JM, Martin JGA.

Ecol Evol. 2018 Nov 14;8(23):11543-11553. doi: 10.1002/ece3.4597. eCollection 2018 Dec.

20.

A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315).

Geller JI, Fox E, Turpin BK, Goldstein SL, Liu X, Minard CG, Kudgus RA, Reid JM, Berg SL, Weigel BJ.

Cancer. 2018 Dec 1;124(23):4548-4555. doi: 10.1002/cncr.31725. Epub 2018 Nov 5. Erratum in: Cancer. 2019 Aug 15;125(16):2896.

21.

Is there indirect selection on female extra-pair reproduction through cross-sex genetic correlations with male reproductive fitness?

Reid JM, Wolak ME.

Evol Lett. 2018 Jun 15;2(3):159-168. doi: 10.1002/evl3.56. eCollection 2018 Jun.

22.

Sex-specific additive genetic variances and correlations for fitness in a song sparrow (Melospiza melodia) population subject to natural immigration and inbreeding.

Wolak ME, Arcese P, Keller LF, Nietlisbach P, Reid JM.

Evolution. 2018 Oct;72(10):2057-2075. doi: 10.1111/evo.13575. Epub 2018 Sep 24.

PMID:
30101430
24.

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma.

DuBois SG, Mosse YP, Fox E, Kudgus RA, Reid JM, McGovern R, Groshen S, Bagatell R, Maris JM, Twist CJ, Goldsmith K, Granger MM, Weiss B, Park JR, Macy ME, Cohn SL, Yanik G, Wagner LM, Hawkins R, Courtier J, Lai H, Goodarzian F, Shimada H, Boucher N, Czarnecki S, Luo C, Tsao-Wei D, Matthay KK, Marachelian A.

Clin Cancer Res. 2018 Dec 15;24(24):6142-6149. doi: 10.1158/1078-0432.CCR-18-1381. Epub 2018 Aug 9.

25.

Clock Drawing Test in acute stroke and its relationship with long-term functional and cognitive outcomes.

Champod AS, Gubitz GJ, Phillips SJ, Christian C, Reidy Y, Radu LM, Darvesh S, Reid JM, Kintzel F, Eskes GA.

Clin Neuropsychol. 2019 Jul;33(5):817-830. doi: 10.1080/13854046.2018.1494307. Epub 2018 Jul 9.

PMID:
29985104
26.

Individual repeatability and heritability of divorce in a wild population.

Germain RR, Wolak ME, Reid JM.

Biol Lett. 2018 Jun;14(6). pii: 20180061. doi: 10.1098/rsbl.2018.0061.

27.

Serum Triamcinolone Levels following Cervical Interlaminar Epidural Injection.

Lamer TJ, Dickson RR, Gazelka HM, Nicholson WT, Reid JM, Moeschler SM, Hooten WM.

Pain Res Manag. 2018 Mar 21;2018:8474127. doi: 10.1155/2018/8474127. eCollection 2018.

28.

A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314).

Schafer ES, Rau RE, Berg S, Liu X, Minard CG, D'Adamo D, Scott R, Reyderman L, Martinez G, Devarajan S, Reid JM, Fox E, Weigel BJ, Blaney SM.

Pediatr Blood Cancer. 2018 Aug;65(8):e27066. doi: 10.1002/pbc.27066. Epub 2018 May 2.

29.

A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.

Chuk MK, Widemann BC, Minard CG, Liu X, Kim A, Bernhardt MB, Kudgus RA, Reid JM, Voss SD, Blaney S, Fox E, Weigel BJ.

Pediatr Blood Cancer. 2018 Aug;65(8):e27077. doi: 10.1002/pbc.27077. Epub 2018 Apr 25.

30.

The Consequences of Polyandry for Sibship Structures, Distributions of Relationships and Relatedness, and Potential for Inbreeding in a Wild Population.

Germain RR, Arcese P, Reid JM.

Am Nat. 2018 May;191(5):638-657. doi: 10.1086/696855. Epub 2018 Feb 28.

PMID:
29693437
31.

Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.

Pinto N, DuBois SG, Marachelian A, Diede SJ, Taraseviciute A, Glade Bender JL, Tsao-Wei D, Groshen SG, Reid JM, Haas-Kogan DA, Reynolds CP, Kang MH, Irwin MS, Macy ME, Villablanca JG, Matthay KK, Park JR.

Pediatr Blood Cancer. 2018 Jul;65(7):e27023. doi: 10.1002/pbc.27023. Epub 2018 Mar 30.

32.

Population and evolutionary dynamics in spatially structured seasonally varying environments.

Reid JM, Travis JMJ, Daunt F, Burthe SJ, Wanless S, Dytham C.

Biol Rev Camb Philos Soc. 2018 Aug;93(3):1578-1603. doi: 10.1111/brv.12409. Epub 2018 Mar 25. Review.

33.

Demographic consequences of invasion by a native, controphic competitor to an insular bird population.

Johnson KM, Germain RR, Tarwater CE, Reid JM, Arcese P.

Oecologia. 2018 May;187(1):155-165. doi: 10.1007/s00442-018-4101-y. Epub 2018 Mar 2.

PMID:
29500488
34.

Age, state, environment, and season dependence of senescence in body mass.

Kroeger SB, Blumstein DT, Armitage KB, Reid JM, Martin JGA.

Ecol Evol. 2018 Jan 18;8(4):2050-2061. doi: 10.1002/ece3.3787. eCollection 2018 Feb.

35.

Corticosteroid and Cortisol Serum Levels Following Intra-articular Triamcinolone Acetonide Lumbar Facet Joint Injections.

Dickson RR, Reid JM, Nicholson WT, Lamer TJ, Hooten WM.

Pain Pract. 2018 Sep;18(7):864-870. doi: 10.1111/papr.12686. Epub 2018 Mar 23.

PMID:
29436106
36.

No evidence of inbreeding depression in sperm performance traits in wild song sparrows.

Losdat S, Germain RR, Nietlisbach P, Arcese P, Reid JM.

Ecol Evol. 2018 Jan 12;8(3):1842-1852. doi: 10.1002/ece3.3721. eCollection 2018 Feb.

37.

Pharmacokinetics of dacarbazine (DTIC) in pregnancy.

Kantrowitz-Gordon I, Hays K, Kayode O, Kumar AR, Kaplan HG, Reid JM, Safgren SL, Ames MM, Easterling TR, Hebert MF.

Cancer Chemother Pharmacol. 2018 Mar;81(3):455-460. doi: 10.1007/s00280-017-3511-6. Epub 2018 Jan 5.

38.

Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213).

Norris RE, Fox E, Reid JM, Ralya A, Liu XW, Minard C, Weigel BJ.

Pediatr Blood Cancer. 2018 May;65(5):e26944. doi: 10.1002/pbc.26944. Epub 2018 Jan 2.

39.

A Phase I Clinical Trial of the Poly(ADP-ribose) Polymerase Inhibitor Veliparib and Weekly Topotecan in Patients with Solid Tumors.

Wahner Hendrickson AE, Menefee ME, Hartmann LC, Long HJ, Northfelt DW, Reid JM, Boakye-Agyeman F, Kayode O, Flatten KS, Harrell MI, Swisher EM, Poirer GG, Satele D, Allred J, Lensing JL, Chen A, Ji J, Zang Y, Erlichman C, Haluska P, Kaufmann SH.

Clin Cancer Res. 2018 Feb 15;24(4):744-752. doi: 10.1158/1078-0432.CCR-17-1590. Epub 2017 Nov 14.

40.

Evolution of precopulatory and post-copulatory strategies of inbreeding avoidance and associated polyandry.

Duthie AB, Bocedi G, Germain RR, Reid JM.

J Evol Biol. 2018 Jan;31(1):31-45. doi: 10.1111/jeb.13189. Epub 2017 Nov 3.

41.

Skeletal and Uterotrophic Effects of Endoxifen in Female Rats.

Gingery A, Iwaniec UT, Subramaniam M, Turner RT, Pitel KS, McGovern RM, Reid JM, Marler RJ, Ingle JN, Goetz MP, Hawse JR.

Endocrinology. 2017 Oct 1;158(10):3354-3368. doi: 10.1210/en.2016-1871.

42.

Feed-backs among inbreeding, inbreeding depression in sperm traits, and sperm competition can drive evolution of costly polyandry.

Bocedi G, Reid JM.

Evolution. 2017 Dec;71(12):2786-2802. doi: 10.1111/evo.13363. Epub 2017 Nov 13.

43.

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.

Goetz MP, Suman VJ, Reid JM, Northfelt DW, Mahr MA, Ralya AT, Kuffel M, Buhrow SA, Safgren SL, McGovern RM, Black J, Dockter T, Haddad T, Erlichman C, Adjei AA, Visscher D, Chalmers ZR, Frampton G, Kipp BR, Liu MC, Hawse JR, Doroshow JH, Collins JM, Streicher H, Ames MM, Ingle JN.

J Clin Oncol. 2017 Oct 20;35(30):3391-3400. doi: 10.1200/JCO.2017.73.3246. Epub 2017 Aug 30.

44.

Comparison of Bioavailability of Single-Dose Extended-Release Venlafaxine Capsules in Obese Patients Before and After Gastric Bypass Surgery.

Krieger CA, Cunningham JL, Reid JM, Langman LJ, Grothe KB, Clark MM, Dierkhising RA.

Pharmacotherapy. 2017 Nov;37(11):1374-1382. doi: 10.1002/phar.2022. Epub 2017 Oct 10.

PMID:
28845898
45.

Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report.

Leary SES, Park JR, Reid JM, Ralya AT, Baruchel S, Wu B, Roberts TPL, Liu X, Minard CG, Fox E, Weigel B, Blaney S.

Clin Cancer Res. 2017 Oct 15;23(20):6062-6069. doi: 10.1158/1078-0432.CCR-16-2882. Epub 2017 Jul 27.

46.

Estimating demographic contributions to effective population size in an age-structured wild population experiencing environmental and demographic stochasticity.

Trask AE, Bignal EM, McCracken DI, Piertney SB, Reid JM.

J Anim Ecol. 2017 Sep;86(5):1082-1093. doi: 10.1111/1365-2656.12703. Epub 2017 Jul 3.

PMID:
28543048
47.

Reproductive performance of resident and migrant males, females and pairs in a partially migratory bird.

Grist H, Daunt F, Wanless S, Burthe SJ, Newell MA, Harris MP, Reid JM.

J Anim Ecol. 2017 Sep;86(5):1010-1021. doi: 10.1111/1365-2656.12691. Epub 2017 Jun 19.

48.

A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111).

Geller JI, Perentesis JP, Liu X, Minard CG, Kudgus RA, Reid JM, Fox E, Blaney SM, Weigel BJ.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26565. Epub 2017 Apr 27.

49.

Pedigree-based inbreeding coefficient explains more variation in fitness than heterozygosity at 160 microsatellites in a wild bird population.

Nietlisbach P, Keller LF, Camenisch G, Guillaume F, Arcese P, Reid JM, Postma E.

Proc Biol Sci. 2017 Mar 15;284(1850). pii: 20162763. doi: 10.1098/rspb.2016.2763.

50.

Disappearance of the hyperdense MCA sign after stroke thrombolysis: implications for prognosis and early patient selection for clot retrieval.

Elofuke P, Reid JM, Rana A, Macleod MJ.

J R Coll Physicians Edinb. 2016 Jun;46(2):81-86. doi: 10.4997/JRCPE.2016.203.

PMID:
27929569

Supplemental Content

Support Center